TransCode Therapeutics, Inc. , the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its Phase I clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback